Skip to content

Epidemiological Study to Assess the Symptoms and Patterns of Diagnosis and Treatment of GERD

Epidemiological Study to Assess the Symptoms and Patterns of Diagnosis and Treatment of the Gastroesophageal Reflux Disease

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00524355
Enrollment
2717
Registered
2007-09-03
Start date
2007-03-31
Completion date
2007-11-30
Last updated
2009-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

GERD

Keywords

GERD, GIS, heartburn, NIS, PPI

Brief summary

To describe the frequency, type and severity of the symptoms in patients visiting the GI or internal physicians, with symptoms consistent with gastroesophageal reflux disease (GERD)

Interventions

None listed

Sponsors

AstraZeneca
Lead SponsorINDUSTRY

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients from both sexes, aged 18 years or older * Patients complaining of symptoms consistent with reflux disease

Exclusion criteria

* Patients with GI cancer and those where the only reason for the visit is renewing the prescription are excluded

Countries

Vietnam

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026